Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial

NCT04855513 is registered in ClinicalTrials.gov with Hamad Medical Corporation as lead sponsor.

NCT NCT04855513
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04855513 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of Pre-eclampsia Using Metformin: a Randomized Control Trial
Lead sponsor
Hamad Medical Corporation
Phase
Not applicable
Overall status
Unknown status
Start date
March 24, 2022
Completion date
December 30, 2023
Enrollment
414 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

eclampsia, high risk pregnancy, preeclampsia, preeclampsia severe